首页|超滤治疗老年心力衰竭合并衰弱患者的有效性及安全性

超滤治疗老年心力衰竭合并衰弱患者的有效性及安全性

Efficacy and safety of ultrafiltration in the treatment for elderly patients with heart failure and frailty

扫码查看
目的 探讨超滤治疗老年心力衰竭(心衰)合并衰弱患者的有效性及安全性.方法 88例老年心衰合并衰弱的住院患者随机分为常规组和超滤组,各44例.常规组给予药物治疗,超滤组在药物治疗的基础上进行超滤治疗,但在超滤治疗期间不使用利尿剂.比较2组疗效评价指标:治疗48 h后患者体质量、N末端B型利钠肽原(NT-proBNP),治疗48 h及1周后呼吸困难难度评分、住院时间、3个月内再次住院率.安全性评价指标:治疗48 h后患者血肌酐、血尿素氮、血钠、血钾,治疗1周后患者血肌酐.结果 疗效评价指标:2组患者治疗48 h后体质量、NT-proBNP均较治疗前降低(P<0.05),治疗前后2组体质量、NT-proBNP差异均无统计学意义(P>0.05);2组治疗48 h后患者呼吸困难难度评分均较治疗前升高,治疗1周后降低,超滤组治疗48 h后呼吸困难难度评分高于常规组(P<0.05);超滤组住院时间和3个月内再住院率均低于常规组(P<0.05).安全性评价指标:治疗前及治疗48 h后2组血尿素氮、血钠差异均无统计学意义(P>0.05),超滤组治疗48 h后血钾高于常规组(P<0.05);常规组治疗前后血肌酐无明显变化(P>0.05);超滤组治疗1周后血肌酐低于治疗前及治疗48 h,且低于常规组(P<0.05).结论 超滤治疗老年心衰合并衰弱是一种安全有效的治疗方法.
Objective To investigate the efficacy and safety of ultrafiltration therapy in elderly patients with congestive heart failure(CHF)and frailty.Methods A total of 88 hospitalized elderly patients with CHF and frailty were randomly assigned to the ultrafiltration group(n=44)and the control group(n=44).The control group treated with standard drug therapy.The ultrafiltration group treated with ultrafiltration,however,diuretics were not used during ultrafiltration treatment.Efficacy assessment was compared between the two groups,including patient body weight,N-terminal pro-brain natriuretic peptide(NT-proBNP)levels at 48 hours after treatment,dyspnea severity scores at 48 hours and 1 week after treatment,hospitalization duration and readmission rate within 3 months.Safety assessment parameters included serum creatinine,urea nitrogen,Na+and K+concentration at 48 hours after treatment and creatinine level 1 week after treatment.Results Efficacy assessment indicated that at 48 hours after treatment,both groups showed a significant reduction in patient body weight and NT-proBNP levels compared to pre-treatment levels(P<0.05).However,there were no significant difference in body weight and NT-proBNP levels before and after treatment between the two groups(P>0.05).Dyspnea severity scores for both groups increased at 48 hours after treatment,then decreased at 1 week after treatment.The ultrafiltration group exhibited higher dyspnea severity scores than that of the control group at 48 hours after treatment(P<0.05).The length of hospital stay and the rate of re-hospitalization within 3 months were lower in the ultrafiltration group compared to those of the control group(P<0.05).Safety assessment revealed that there were no significant differences in serum urea nitrogen and Na+levels before and 48 hours after treatment between the two groups(P>0.05).However,serum K+levels were higher after 48-hours treatment in the ultrafiltration group than those of the control group(P<0.05).There were no significant changes in creatinine levels before and after treatment in the control group(P>0.05),while creatinine levels were lower 1 week after treatment in the ultrafiltration group compared to those of pre-treatment and 48 hours after treatment,and were lower than those of the control group(P<0.05).Conclusion Ultrafiltration is a safe and effective method for elderly patients with CHF and frailty.

heart failurefrailtyagedultrafiltration

徐斌、诸赟、陈浩、朱红俊、高枫、夏丛奕、钟玲、苏伟

展开 >

无锡市中医医院心血管内科(邮编 214071)

心力衰竭 衰弱 老年人 超滤

无锡市中医药管理局科技项目重点项目无锡市科技发展指导性计划(医疗卫生)项目无锡市"太湖人才计划"医疗卫生高层次人才项目(2020年度)

ZYZD01CSZON1618

2024

天津医药
天津市医学科学技术信息研究所

天津医药

CSTPCD
影响因子:1.107
ISSN:0253-9896
年,卷(期):2024.52(7)
  • 5